Acknowledgement
3 business days
BioGate Precision Medicine Corp.
EA Therapies for Single Patient

BGM-2121 - Investigational therapy; single-patient expanded access requests will be evaluated on a case-by-case basis.

EA Policies for Single Patient

BioGate Precision Medicine will evaluate requests for single-patient access to BGM-2121 on a case-by-case basis, considering medical need, available clinical and nonclinical information, potential benefits and risks, drug availability, and applicable FDA and IRB requirements.